When will the FDA approve Nomlafobusp?

José Lopes, PhD avatar

by José Lopes, PhD |

Share this article:

Share article via email
A

When will the FDA approve Nomlafobusp?

Category: CTI-1601

Nomlafobusp is in the early stages of clinical testing and is currently undergoing an extension study of a completed Phase 2 trial in people with Friedreich’s ataxia.

Print This Page

About the Author

José Lopes, PhD avatar
José Lopes, PhD José holds a PhD in neuroscience from the University of Porto, Portugal. After postdocs at Weill Connell Medicine and Western University, where he studied the processes driving hypertension and Alzheimer’s disease, he moved on in 2016 to a career in science writing and communication. José is the author of several peer-reviewed papers and a book chapter and has presented his research in numerous international meetings.

Recent Posts


Recommended reading